Melanoma
From the Journals
New melanoma treatments linked to mortality decline
Melanoma incidence in the U.S. has continued to rise, but BRAF inhibitors and immune checkpoint inhibitors are extending survival, data suggest....
From the Journals
Teledermoscopy using smartphones fails to boost skin cancer detection
From the Journals
Patients accept artificial intelligence in skin cancer screening
Although patient and clinician artificial intelligence tools were acceptable to most patients surveyed, 94% emphasized the importance of a human...
Conference Coverage
Data overwhelmingly support use of dermoscopy in practice
LAHAINA, HAWAII – At clinics where dermoscopy is used, “two-thirds of the melanomas being detected now lack the classic ABCD features of melanoma...
From the Journals
Banning indoor tanning devices could save lives and money
Banning indoor tanning in the United States, Canada, and Europe could result in 187,481 fewer deaths from melanoma and save $5.7 billion.
From the Journals
Smartphone apps for suspicious skin lesions unreliable
"Regulators need to become alert to the potential harm that poorly performing algorithm-based diagnostic or risk monitoring apps create."
Case Letter
Pembrolizumab-Induced Lobular Panniculitis in the Setting of Metastatic Melanoma
Pembrolizumab may cause lobular panniculitis years after treatment initiation. The authors report a case of pembrolizumab-induced, self-limited...
Case Reports
Metastatic Melanoma Mimicking Eruptive Keratoacanthomas
Metastatic melanoma may mimic many other cutaneous processes that may make the diagnosis more difficult. This case indicates that cutaneous...
Tips
Infographic: Applications for the Ketogenic Diet in Dermatology
The ketogenic diet has a good safety and efficacy profile if administered by a knowledgeable provider. Dermatologists should be...
From the Journals
Sharp declines for lung cancer, melanoma deaths fuel record drop in cancer mortality
Reductions in smoking are largely responsible for the lung cancer progress, while immunotherapy and targeted treatments have improved survival in...
From the Journals
New toxicity subscale measures QOL in cancer patients on checkpoint inhibitors
With further validation, the instrument could become an important tool for evaluation of treatment-related toxicity.